Simple position changes may ease newborn pain during routine blood tests

NCT ID NCT07479589

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 120 full-term newborns to see if placing them in different positions (on their back, side, or stomach) during a heel stick blood test could lower their pain and improve comfort. Researchers measured pain using standard scales and checked heart rate and oxygen levels. The goal was to find a simple, drug-free way to make this common procedure less stressful for babies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

120 people

The number who actually took part.

Started

Oct 2023

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

1 day to 28 days

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The newborn must be at term (born at 38 weeks or later) * The newborn must be in the neonatal period (0-28 day) * Their vital signs must be stable * They must have spontaneous breathing * The heel prick blood sample must be taken by the same nurse * The lancet must be inserted only once during the heel prick blood sample collection * The newborn must have been fed at least 30 minutes prior * The families must consent to participate in the study and sign the informed consent form. Exclusion Criteria: * Having a congenital anomaly * Having received pain medication in the last 24 hours * Having received sedatives in the last 24 hours, * Having received oxygen therapy * Having a congenital anomaly * Having a history of seizures * Having a health problem that prevents positioning.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Newborn; vitality are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Public Hospital

    Karaman, Karaman, 7000, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.